The cell-free fetal dna testing market is expected to have a CAGR of 10.9%. By 2023, the market is anticipated to be worth US$ 1,466.3 million, and by 2033, it’s anticipated to be worth US$ 4,124.7 ...

NEWARK, Del, March 10, 2025 (GLOBE NEWSWIRE) -- The global cell-free fetal DNA testing market is poised for steady growth, projected to reach USD 1,687.8 million by 2025 and expanding at a CAGR of 6.1 ...

Cell-Free Fetal DNA Testing Market research Report is an inestimable supply of insightful data for business strategists. This Cell-Free Fetal DNA Testing Market study provides extensive data which ...

The prospective, blinded, multi-site study is evaluating Natera’s Fetal Focus single gene noninvasive prenatal test for inherited conditions. Initiated in 2023, the EXPAND trial is designed to confirm ...

Two professional societies have released comments on the use of cell-free fetal (cff) DNA noninvasive prenatal testing (NIPT) to detect trisomies in low-risk pregnant women. The statements follow ...

Cell-free DNA analysis of maternal plasma is easy ,non- invasive and highly effective in detecting fetal chromosomal and genetic abnormalities in antenatal mothers Cell-free DNA (cfDNA) analysis is a ...